Journals / İstanbul Medical Journal / 2016 / Cilt: 17 - Sayı: 2

Baş-boyun Skuamöz Hücreli Karsinomlarında Lokal Nüksün Saptanmasında Difüzyon Ağırlıklı MR ve FDG PET/BT'nin Tanısal Performansı

Diagnostic Performance of Diffusion-Weighted MRI and FDG PET/CT for Detecting the Local Recurrence of Head and Neck Squamous Cell Carcinoma

Pages
48–53
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

PET/CT images were acquired after the administration of 3.7 MBq/kg of fluorine-18-fluorodeoxyglucose, and the images were acquired 1 h later.Results: The apparent diffusion coefficient (ADC)mean values of the recurrence group were significantly lower than those of the post-treatment changes group (0.773 vs. 1.588×10-3 mm2/s, respectively; p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To compare the efficacy between diffusion-weighted magnetic resonance imaging (DW-MRI) and positron emission tomography/computed tomography (PET/CT) in detecting the local recurrence of head and neck squamous cell carcinoma (HNSCC) following treatment in the same patient group.
📊
Key Findings & Data:The median delay times between radiotherapy and MRI and between MRI and FDG PET/CT were 71 days (range: 43-98 days) and 75 days (range: 44-103 days), respectively.
💡
Conclusion & Impact:PET/CT images were acquired after the administration of 3.7 MBq/kg of fluorine-18-fluorodeoxyglucose, and the images were acquired 1 h later.Results: The apparent diffusion coefficient (ADC)mean values of the recurrence group were significantly lower than those of the post-treatment changes group (0.773 vs. 1.588×10-3 mm2/s, respectively; p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To compare the efficacy between diffusion-weighted magnetic resonance imaging (DW-MRI) and positron emission tomography/computed tomography (PET/CT) in detecting the local recurrence of head and neck squamous cell carcinoma (HNSCC) following treatment in the same patient group. Methods: Twenty-three patients who had biopsy-proven HNSCC were enrolled. All patients were treated with radiotherapy and followed up with MRI and PET/CT. The median delay times between radiotherapy and MRI and between MRI and FDG PET/CT were 71 days (range: 43-98 days) and 75 days (range: 44-103 days), respectively. Diffusion-weighted single-shot echo planar imaging was performed before contrast injection at b values of 0 and 1000 s/mm2. PET/CT images were acquired after the administration of 3.7 MBq/kg of fluorine-18-fluorodeoxyglucose, and the images were acquired 1 h later.Results: The apparent diffusion coefficient (ADC)mean values of the recurrence group were significantly lower than those of the post-treatment changes group (0.773 vs. 1.588×10-3 mm2/s, respectively; p

Özet

Amaç: Baş-boyun skuamöz hücreli karsinom (SCC) lokal nüksün saptanmasında difüzyon ağırlıklı manyetik rezonans görüntüleme (DA-MRG) ve pozitron emisyon tomografi/bilgisayarlı tomografi (PET/BT) etkinliğini karşılaştırmak.Yöntemler: Baş-boyun SCC tanısı biyopsi ile kanıtlanmış ve radyoterapi ile tedavi edilen 23 hasta çalışmaya dahil edildi. Takipte tüm hastalardan MRG ve PET/BT incelemesi yapıldı. Tedavinin tamamlanması ile MR ve PET/BT incelemleri arasındaki ortalama süre sırasıyla 70,30 gün ve 76,34 gün idi. Difüzyon ağırlıklı single-shot eko planar görüntüleme 0 ve 1000 sn/mm2 b değerlerinde kontrast enjeksiyonundan önce yapıldı. PET/BT görüntüleri flor-18-fluorodeoksiglukoz (3.7 MBq/kg) verilmesinden 1 saat sonra görüntüler elde edildi.Bulgular: Nüks saptanan hastalarda ADCortalama değerleri saptanmayan hastalarla karşılaştırıldığında istatistiksel olarak anlamlı derecede düşük bulunmuştur (0,773'e karşı 1,588 x10-3/mm2 sırasıyla, p

🔖

Cite This Article

ÖZ, İ. İ., BÜYÜKUYSAL, M. Ç., DAMAR, M., SALİHOĞLU, Y. S., ERDEM, O., ŞERİFOĞLU, İ., DİNÇ, A. E., USLU, R. (2022). Baş-boyun Skuamöz Hücreli Karsinomlarında Lokal Nüksün Saptanmasında Difüzyon Ağırlıklı MR ve FDG PET/BT'nin Tanısal Performansı. İstanbul Medical Journal, Cilt: 17 - Sayı: 2, 48–53. https://ajindex.com/articles/552107

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Tshering Vogel DW, Zbaeren P, Geretschlaeger A, Vermathen P, De Keyzer F, Thoeny HC. Diffusion-weighted MR imaging including bi- exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers. Eur Radiol 2013
  2. [CrossRef] Hwang I, Choi SH, Kim YJ, Kim KG, Lee AL, Yun TJ, et al. Differentiation of recurrent tumor and posttreatment changes in head and neck squa- mous cell carcinoma: application of high b-value diffusion-weighted imaging. AJNR Am J Neuroradiol 2013
  3. [CrossRef] Abgral R, Querellou S, Potard G, Le Roux PY, Le Duc-Pennec A, Marianovski R, et al. Does 18F-FDG PET/CT improve the detection of posttreatment re- currence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up? J Nucl Med 2009
  4. [CrossRef] Razek AAKA, Kandeel AY, Soliman N, El-Shenshawy HM, Kamel Y, Nada N, et al. Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. American journal of neuroradiology 2007
  5. [CrossRef] Razek AA. Diffusion-weighted magnetic resonance imaging of head and neck. J Comput Assist Tomogr 2010
  6. [CrossRef] Thoeny HC, De Keyzer F, King AD. Diffusion-weighted MR imaging in the head and neck. Radiology 2012
  7. [CrossRef] Payne KF, Haq J, Brown J, Connor S. The role of diffusion-weighted magnetic resonance imaging in the diagnosis, lymph node staging and assessment of treatment response of head and neck cancer. Int J Oral Maxillofac Surg 2015
  8. [CrossRef] Choi SH, Paeng JC, Sohn CH, Pagsisihan JR, Kim YJ, Kim KG, et al. Cor- relation of 18F-FDG uptake with apparent diffusion coefficient ratio measured on standard and high b value diffusion MRI in head and neck cancer. J Nucl Med 2011
  9. [CrossRef] Varoquaux A, Rager O, Lovblad KO, Masterson K, Dulguerov P, Ratib O, et al. Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV. Eur J Nucl Med Mol Imaging 2013
  10. [CrossRef] Burger IA, Huser DM, Burger C, von Schulthess GK, Buck A. Repeatability of FDG quantification in tumor imaging: averaged SUVs are superior to SUV_____ sub> max_____/sub>. Nucl Med Biol 2012
  11. [CrossRef] Nakajo M, Nakajo M, Kajiya Y, Tani A, Kamiyama T, Yonekura R, et al. FDG PET/CT and diffusion-weighted imagin